Trevi Therapeutics Inc (NASDAQ: TRVI) kicked off on Tuesday, down -1.60% from the previous trading day, before settling in for the closing price of $5.95. Over the past 52 weeks, TRVI has traded in a range of $2.36-$7.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 27.09% over the last five years. While this was happening, its average annual earnings per share was recorded 8.52%. With a float of $69.87 million, this company’s outstanding shares have now reached $99.89 million.
The firm has a total of 26 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Trevi Therapeutics Inc (TRVI) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Trevi Therapeutics Inc is 41.36%, while institutional ownership is 44.02%. The most recent insider transaction that took place on Mar 25 ’25, was worth 17,365. In this transaction Chief Scientific Officer of this company sold 2,631 shares at a rate of $6.60, taking the stock ownership to the 221,373 shares. Before that another transaction happened on Mar 21 ’25, when Company’s President & CEO sold 5,263 for $6.58, making the entire transaction worth $34,625. This insider now owns 213,313 shares in total.
Trevi Therapeutics Inc (TRVI) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.29% during the next five years compared to 27.09% growth over the previous five years of trading.
Trevi Therapeutics Inc (NASDAQ: TRVI) Trading Performance Indicators
Take a look at Trevi Therapeutics Inc’s (TRVI) current performance indicators. Last quarter, stock had a quick ratio of 15.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.45, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.54 in one year’s time.
Technical Analysis of Trevi Therapeutics Inc (TRVI)
Analysing the last 5-days average volume posted by the [Trevi Therapeutics Inc, TRVI], we can find that recorded value of 1.77 million was lower than the volume posted last year of 1.85 million. As of the previous 9 days, the stock’s Stochastic %D was 75.95%.
During the past 100 days, Trevi Therapeutics Inc’s (TRVI) raw stochastic average was set at 56.19%, which indicates a significant increase from 41.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.31 in the past 14 days, which was lower than the 0.42 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.28, while its 200-day Moving Average is $4.68. Now, the first resistance to watch is $6.03. This is followed by the second major resistance level at $6.21. The third major resistance level sits at $6.33. If the price goes on to break the first support level at $5.73, it is likely to go to the next support level at $5.61. Now, if the price goes above the second support level, the third support stands at $5.43.
Trevi Therapeutics Inc (NASDAQ: TRVI) Key Stats
The company with the Market Capitalisation of 697.59 million has total of 117,293K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -47,910 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -10,340 K.
